Statera Biopharma Inc (NASDAQ:STAB) company share is currently trading in the red. The group confirmed that it would participate in the Cantor Global Healthcare Conference, which will be hosted virtually. In addition, the biopharmaceutical company went on record and confirmed that Michael K. Handley, President and CEO of Statera Biopharma Inc, is slated to participate in the virtual conference.
Initially the company was known as Cytocom, Inc. It is a biopharmaceutical company that develops solutions to treat various medical conditions and cancers. The various medical solutions are designed and introduced to impact patient’s immune system.
It has come to light that the leading biopharmaceutical company is working on developing solutions in the form of therapies that are designed to targeting the specific T-cells, which are also known as killer cells. In addition, the group is expanding its research and development activity to treat multiple sclerosis.
Market Reaction:
On Friday, STAB stock went down 1% at $2.29 with more than 261k shares, compared to its average volume of 279K shares. The stock has moved within a range of $2.2000 – 2.4100 after opening the trade at $2.28.
